Keep current with news you can use and participate in events

News & Events

Breaking News


FSH Society Fellow Dr. Scott Harper Discusses DUX4 as a Potential Candidate Gene

Friends and families! The 2010 Fundraising Challenge was successful, raising $221,000! Thanks very much to all of you who participated and Happy New Year 2011


Scientific Advisory Board funds five new research awards


FSHD is shown to be the most Prevalent Muscular Dystrophy! Consortium of European government and private partners releases report showing that Facioscapulohumeral Muscular Dystrophy.


FSH Society helps fund second critical advance in determining the cause of FSHD PLoS Genetics, “Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene.”


FSH Society 2010 IRC Planning Meeting Consensus of Tactical and Strategic Research Priorities for FSHD


Program and Abstracts 2010 FSHD International Research Consortium Workshop and Research Planning Meeting October 21-22, 2010


Latest FSH Watch Newsletter Research Issue can be found here!


FEB
26
FSH Society Fellow Dr. Scott Harper Discusses DUX4 as a Potential Candidate Gene for Facioscapulohumeral Muscular Dystrophy


FSH Society funded researchers at Nationwide Children’s Hospital have a monthly podcast series entitled “This Month in Muscular Dystrophy”.  February’s podcast is on DUX4 as a Potential Candidate Gene for Facioscapulohumeral Muscular Dystrophy. Dr. Kevin Flanigan interviews Dr. Scott Harper at Nationwide Children's Hospital about DUX4 as a Potential Candidate Gene for Facioscapulohumeral Muscular Dystrophy (FSHD). FSHD patients and their families should be aware of the following educational and informative Podcast on FSHD, D4Z4, DUX4, AAV and P53.  About 20 minutes in length it is very informative for those wishing a lay audience level discussion of recent advances in our understanding of FSHD.

Nationwide Children's Hospital
"This Month in Muscular Dystrophy"
Podcasts Dedicated to the Latest Neuromuscular Research

Hosted by Kevin Flanigan, MD, "This Month in Muscular Dystrophy" podcasts highlight the latest in muscular dystrophy and other inherited neuromuscular disease research.  During each podcast, authors of recent publications discuss how their work improves o  ur understanding of inherited neuromuscular diseases, and what their work might mean for treatment of these diseases.

Featured Podcasts

February 2011: Dr. Scott Harper Discusses DUX4 as a Potential Candidate Gene for Facioscapulohumeral Muscular Dystrophy.

Click HERE to listen to the Podcast

This was initiated and supported by several FSH Society fellowship grants. The acknowledgements in the paper are as follows:

“Acknowledgments

This work was financially supported by the Facioscapulohumeral Society Landsman Charitable Trust Research Fellowship Grant (FSHD-LCT-002, to S.Q.H.) and Conners and Jacobs Families Research Fellowship Grant (FSHS-JJFR-001, to S.Q.H.), and a National Institutes of Health (NIH) KL2 Clinical and Translational Scholar Award (KL2 RR025754, to S.Q.H.). Additional support was provided by startup funds to S.Q.H. and a Graduate Student Fellowship to L.M.W. from the Research Institute at Nationwide Children’s Hospital Research Foundation.

We thank members of the Harper laboratory for assistance and support, Dr. S. Hauschka for providing the MHCK7 promoter, Dr. P. Martin for Trp53 mice, Dr. Yi-Wen Chen for DUX4 antibodies, Mr. D. P. Perez for advice and support, and Dr. K. R. Clark and TRINCH Viral Vector Core Facility members for assistance with AAV production.”

Listen to this Podcast

Guest: Scott Harper, Ph.D., Nationwide Children's Hospital

Access an abstract of this Month's Featured Research Article: DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol. 2010 Oct 28. [Epub ahead of print].

The FSH Society thanks you for generously supporting advances in research, education, outreach and advocacy.

 

TEXT SIZE  minus plus

FSH Society, Inc. • 64 Grove Street • Watertown, MA 02472 • Tel: 617 658-7878 • Fax: 617 658-7879